The agonist activity of tamoxifen is inhibited by the short heterodimer partner orphan nuclear receptor in human endometrial cancer cells

Carolyn M. Klinge, Sarah C. Jernigan, Kelly E. Risinger

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

Short heterodimer partner (SHP) is an orphan nuclear receptor that interacts with ERα and ERβ and inhibits E2-induced transcription. We examined how SHP affects tamoxifen's estrogen agonist activity in endometrial cells. We report that SHP interacts with 4-hydroxytamoxifen (4-OHT) or E2-occupied ERα in a temperature-dependent manner in vitro. In transient transfection assays, SHP inhibited 4-OHT-stimulated reporter gene activity from an estrogen response element (ERE) in ER-positive RL95-2 but not in HEC-1A human endometrial carcinoma cells transfected with ERα or ERβ. SHP inhibited E2-induced transcriptional activity in ERα- or ERβ-transfected HEC-1A or Chinese hamster ovary-K1 cells. SHP inhibition of E2 activity was greater for ERα than ERβ from the nonpalindromic ERE in the pS2 gene promoter in Chinese hamster ovary-K1 but not HEC-1A cells. Thus, ER subtype, cell type, and ERE sequence influence SHP repressor activity. An ERα mutant lacking activator function-1 showed reduced inhibition by SHP. In glutathione S-transferase pulldown experiments, SHP inhibited ERα dimerization, providing a possible mechanism to account for the inhibitory effect of SHP on ER activity. These results identify SHP as novel target for blocking 4-OHT agonist activity in endometrial cells.

Original languageEnglish (US)
Pages (from-to)853-867
Number of pages15
JournalEndocrinology
Volume143
Issue number3
DOIs
StatePublished - 2002

ASJC Scopus subject areas

  • Endocrinology

Fingerprint Dive into the research topics of 'The agonist activity of tamoxifen is inhibited by the short heterodimer partner orphan nuclear receptor in human endometrial cancer cells'. Together they form a unique fingerprint.

Cite this